Conferences - Results from #8300

AUA 2016: Ureteral strictures after ureteroscopy for nephrolithiasis: Multi-Institutional Outcomes - Poster Session Highlights May 9, 2016

AUA 2016: A novel technique of suctioning flexible ureteroscopy with automatic control of renal pelvic pressure: an initial experience of 37 cases - Poster Session Highlights May 9, 2016

AUA 2016: The Impact of Infectious Complications after Prostate Biopsy on Radical Prostatectomy Surgical Outcomes: A Population-Based Analysis - Poster Session Highlights May 9, 2016

AUA 2016: The Effect of Smoking on 30-Day Morbidity Following Malignancy-Related Prostatectomy - Poster Session Highlights May 9, 2016

AUA 2016: BRCA Gene Mutations Associated With Increased Prostate Cancer Risk May 9, 2016

AUA 2016: Robotic Assisted Laparoscopic Ipsilateral Ureteroureterostomy: A Report of Efficacy and Comparison to Open Surgery - Poster Session Highlights May 9, 2016

AUA 2016: Stone Dusting: A Value-Based Model to Inform Management of Small Renal Mass - Session Highlights May 9, 2016

AUA 2016: Stone Dusting: Repeat Stone Surgery: Clinical Validation of Administrative Claims - Session Highlights May 9, 2016

AUA 2016: A randomized study of intra-operative autologous retropubic urethral sling on urinary control after robot assisted radical prostatectomy - Poster Session Highlights May 9, 2016

AUA 2016: Emergency Department Switching and Duplicate CT Scans in Patients with Kidney Stones - Poster Session Highlights May 9, 2016

AUA 2016: Long-term follow-up circulating tumor cells as predictors for survival in men treated with abiraterone acetate for castration resistant prostate cancer following chemotherapy - Session Highlights May 9, 2016

AUA 2016: Gene Expression Analysis of Bone Metastasis and Circulating Tumor Cells from Metastatic Castrate-resistant Prostate Cancer Patients - Session Highlights May 9, 2016

AUA 2016: Galeterone shows anti-tumor activity in multiple pre-clinical models that express androgen receptor splice variants, supporting correlative patient data seen in ARMOR2 - Session Highlights May 9, 2016

AUA 2016: Long-term safety and antitumor activity of ODM-201 in chemotherapy and CYP17-inhibitor naïve patients from the ARADES and the ARAFOR trials - Session Highlights May 9, 2016

AUA 2016: Defining Deliverables of Multiparametric Magnetic Resonance Imaging (mpMRI)/Ultrasound (US) Fusion-Guided Targeted Prostate Biopsy: Actionable Intelligence Metric (AIM) and Reduction Metric (RM) - Session Highlights May 9, 2016

AUA 2016: Relationship of Post-operative Chronic Kidney Disease Subtype Status and Outcomes in Patients Undergoing Renal Surgery - Session Highlights May 9, 2016

AUA 2016: Impact of Abiraterone Acetate in Prostate Specific AntiGEN Trial Update: Effect of abiraterone acetate and low dose prednisone on prostate-specific antigen and radiographic disease progression in patients with nmCRPC May 9, 2016

AUA 2016: Study of PSMA-Targeted 18F-DCFPyL PET/CT in the Evaluation of Men with an Elevated PSA Following Radical Prostatectomy - Session Highlights May 9, 2016

AUA 2016: Radium-223 re-treatment: Experience from an international, multicenter, prospective study in patients with castration-resistant prostate cancer and bone metastases - Session Highlights May 9, 2016

AUA 2016: Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer - Session Highlights May 9, 2016

Page 416 of 507